Fernández Carmen, López-Herce Jesús, Flores Jose C, Galaviz Dolores, Rupérez Marta, Brandstrup Kay B, Bustinza Amaya
Pediatric Intensive Care Unit, Gregorio Marañón Hospital, Madrid, Spain.
Pediatr Nephrol. 2005 Oct;20(10):1473-7. doi: 10.1007/s00467-005-1907-8. Epub 2005 Jul 27.
We performed an observational prospective study in 53 critically ill children to analyze the prognostic factors of children requiring continuous renal replacement therapy. Pediatric index of mortality (PIM), pediatric risk of mortality score (PRISM), multi-organ failure score, serum lactate levels, blood pressure, vasoactive drugs, renal function and characteristics of renal replacement therapy were analyzed. The mortality was 32.1%, with multi-organ failure being the most frequent cause of death (59%). The children who died presented a significantly lower blood pressure and required more doses of vasoactive drugs, dopamine and epinephrine than did the survivors. The PRISM and PIM scores and the serum lactate levels and the number of organs suffering failure were significantly higher in the patients who died than in the survivors. However, the PRISM and PIM scores underestimated the risk of mortality. The age, sex, urea and creatinine levels, type of pump and volume of ultrafiltrate did not affect the prognosis. The association of a mean BP<55 mmHg and epinephrine dose >0.6 mug/kg/min was predictive of mortality in 76% of the patients. We conclude that the prognosis in children requiring renal replacement therapy depends on the severity of the clinical state at the time of starting therapy, principally on the hemodynamic situation.
我们对53名危重症儿童进行了一项前瞻性观察研究,以分析需要持续肾脏替代治疗的儿童的预后因素。分析了小儿死亡率指数(PIM)、小儿死亡风险评分(PRISM)、多器官功能衰竭评分、血清乳酸水平、血压、血管活性药物、肾功能以及肾脏替代治疗的特点。死亡率为32.1%,多器官功能衰竭是最常见的死亡原因(59%)。死亡儿童的血压明显低于幸存者,且需要比幸存者更多剂量的血管活性药物、多巴胺和肾上腺素。死亡患者的PRISM和PIM评分、血清乳酸水平以及发生功能衰竭的器官数量均显著高于幸存者。然而,PRISM和PIM评分低估了死亡风险。年龄、性别、尿素和肌酐水平、泵的类型以及超滤量均不影响预后。平均血压<55 mmHg且肾上腺素剂量>0.6 μg/kg/min与76%的患者死亡率相关。我们得出结论,需要肾脏替代治疗的儿童的预后取决于开始治疗时临床状态的严重程度,主要取决于血流动力学状况。